iShares MSCI Emerging Markets Value Factor ETF (EVLU)
Live price chart, market sentiment, and community perspectives for iShares MSCI Emerging Markets Value Factor ETF (CBOE: EVLU).
Live price chart, market sentiment, and community perspectives for iShares MSCI Emerging Markets Value Factor ETF (CBOE: EVLU).
On our trading desk, we are closely tracking EVLU's liquidity footprint. With assets under management lingering around $14.1M to $14.8M, execution requires tight discipline. While the 0.35% expense ratio is attractive for a factor-based emerging markets strategy, the shallow institutional sponsorship means wider bid-ask spreads during market stress. We are advising clients to scale entries carefully rather than placing aggressive block orders.
When evaluating factor exposures for portfolio construction, our quantitative research group notes that EVLU delivers a differentiated value-style mandate across large- and mid-cap emerging market equities. Morningstar peer assessments categorize both risk and return as low over multi-year windows, which correlates with delivering less absolute category volatility at the expense of upside participation compared to broader diversified offerings like EEM or VWO.
Looking at the risk analytics, EVLU presents an interesting paradox. The fund's 1-year beta sits at 0.77—notably lower than the 0.90 to 1.10 range typical of category peers. However, the 3-year downside-capture ratio of 103 flags that it absorbs slightly more benchmark downside than anticipated during corrective phases. Investors should weigh this localized downside sensitivity against the fund's solid trailing yield of 3.78% and its focus on the MSCI Emerging Markets Value Factor Select Index.
On our risk management desk, we ran drawdown simulations using the reported 5-year benchmark maximum drawdown of -33.5% (slightly shallower than the category average of -34.6%). While the index demonstrates modest downside discipline at the structural level, EVLU's short operating history since its September 2024 inception means long-term stress-testing data is still evolving. Position sizing must account for emerging market idiosyncratic risks.
From a market sentiment perspective, the absolute return figures—such as the 54.09% 1-year return and a 2026 YTD return approaching 27.73%—tend to attract initial interest from tactical allocators. Yet, looking at Q1 regulatory filings showing only 4 institutional funds holding roughly $3.28M in total capital, it is clear that broader institutional adoption remains nascent for this September 2024 vintage ETF.
As a portfolio analyst preparing allocation reviews, I focus heavily on yield components. EVLU posts a 30-day SEC yield of 2.46% alongside a 12-month trailing yield of 3.84%. For clients seeking income combined with a quantitative value factor tilt rather than purely growth-oriented emerging market tech exposure, these metrics provide a constructive foundational talking point during portfolio reviews.
Explore plasma cleansing, somatic organ swaps, and BCI.